1-7 of 7
Thomas M. Schmitt
Close
Sort by
Journal Articles

Elevated Metabolite Secretion Facilitates a Treg-Mediated Immunosuppressive Microenvironment in the Solid Tumor

Sinéad Kinsella, Colton W Smith, Kelly McKenna, Menna Hailemariam, Francesco Mazziotta, Lauren E Martin, Shihong Zhang, Tzu-Hao Tang, Jonathan Linton, Thomas M Schmitt, Anthony Rongvaux, Aude G Chapuis
Journal: Blood
Blood (2023) 142 (Supplement 1): 3458.
https://doi.org/10.1182/blood-2023-189868
Published: 2023
Journal Articles

A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia

Shannon K. Oda, Andrew W. Daman, Nicolas M. Garcia, Felecia Wagener, Thomas M. Schmitt, Xiaoxia Tan, Aude G. Chapuis, Philip D. Greenberg
Journal: Blood
Blood (2017) 130 (22): 2410–2419.
https://doi.org/10.1182/blood-2017-04-777052
Published: 2017
Includes: Supplemental data
Journal Articles

EBV-Specific Donor Cells Transduced to Express a High-Affinity WT1 TCR Can Prevent Recurrence in Post-HCT Patients with High-Risk AML

Aude Chapuis, MD, Daniel N. Egan, MD, Merav Bar, MD, Thomas M Schmitt, PhD, Megan McAfee, PhD, Maurizio Perdicchio, PhD, Gunnar B. Ragnarsson, MD MSc, Cecilia C.S. Yeung, Hieu Nguyen, Lara Kropp, Luca Castelli, PhD, Felecia Wagener, Daniel Hunter, Kristen Cohen, PhD, Aaron Seese, Margaret (Julie) McElrath, MD PhD, Kieu-Thu Bui, RN, Deborah E Banker, PhD, Natalie Duerkopp, Philip D Greenberg, MD
Journal: Blood
Blood (2016) 128 (22): 1001.
https://doi.org/10.1182/blood.V128.22.1001.1001
Published: 2016
Journal Articles

Transferred Donor-Derived Virus Specific CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor Can Persist and Provide Anti-Leukemic Activity in AML Patients Post-Transplant

Merav Bar, MD, Aude G. Chapuis, MD, Thomas M Schmitt, PhD, Hieu Nguyen, Natalie A Duerkopp, Mark F Tom, Felecia D Wagener, Colette N Chaney, RN, Kieu-Thu Bui, RN, Shelly Heimfeld, PhD, Philip D. Greenberg, MD
Journal: Blood
Blood (2014) 124 (21): 3939.
https://doi.org/10.1182/blood.V124.21.3939.3939
Published: 2014
Journal Articles

Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection

Thomas M. Schmitt, David H. Aggen, Ingunn M. Stromnes, Michelle L. Dossett, Sarah A. Richman, David M. Kranz, Philip D. Greenberg
Journal: Blood
Blood (2013) 122 (3): 348–356.
https://doi.org/10.1182/blood-2013-01-478164
Published: 2013
Includes: Supplemental data
Journal Articles

The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor

Michael Hudecek, Thomas M. Schmitt, Sivasubramanian Baskar, Maria Teresa Lupo-Stanghellini, Tetsuya Nishida, Tori N. Yamamoto, Marie Bleakley, Cameron J. Turtle, Wen-Chung Chang, Harvey A. Greisman, Brent Wood, David G. Maloney, Michael C. Jensen, Christoph Rader, Stanley R. Riddell
Journal: Blood
Blood (2010) 116 (22): 4532–4541.
https://doi.org/10.1182/blood-2010-05-283309
Published: 2010
Includes: Supplemental data
Journal Articles

CD8 + T Cells Engineered to Express a ROR1-Specific Chimeric Antigen Receptor Specifically Recognize ROR1 Positive B Cell Tumors.

Michael Hudecek, MD, Thomas M Schmitt, PhD, Sivasubramanian Baskar, PhD, Wen-Chung Chang, David G Maloney, MD, PhD, Michael C Jensen, M.D., Christoph M. Rader, Ph.D., Stanley Riddell, MD
Journal: Blood
Blood (2009) 114 (22): 930.
https://doi.org/10.1182/blood.V114.22.930.930
Published: 2009